Opioid Treatment Access Act of 2022

Senate Bill 3629 - Opioid Treatment Access Act of 2022: Overview, Status, and Impact

Hozzl · 2022-12-29T21:18:18Z

Explore the details of Senate Bill 3629 Opioid Treatment Access Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 9:18 PM

Congressional Summary of S 3629

Opioid Treatment Access Act of 2022

This bill expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs.

Specifically, the Department of Health and Human Services (HHS) must issue regulations to further increase patients' access to unsupervised use or handling of drugs for treatment. The Substance Abuse and Mental Health Services Administration (SAMHSA) must study the effects of these revisions, and HHS must, as appropriate, promulgate additional regulations based on the study's findings.

SAMHSA must also study the impact of certain exemptions from certification requirements for opioid treatment programs that were granted as part of COVID-19 response efforts, including any additional costs or savings that resulted from the exemptions.

The bill also (1) allows specified types of health care providers to prescribe (subject to certain requirements) methadone that is dispensed through pharmacies for a patient's unsupervised use, and (2) provides statutory authority for a regulation that allows registered opioid treatment programs to operate mobile medication units without separately registering the unit.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3629

Bill S 3629 is currently in the status of Bill Introduced since February 10, 2022. Bill S 3629 was introduced during Congress 117 and was introduced to the Senate on February 10, 2022. Bill S 3629's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of February 10, 2022

Bipartisan Support of Bill S 3629

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3629

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Cardiovascular and respiratory health

- Congressional oversight

- Department of Health and Human Services

- Drug therapy

- Drug trafficking and controlled substances

- Drug, alcohol, tobacco use

- Emergency medical services and trauma care

- Government information and archives

- Government studies and investigations

- Health care coverage and access

- Infectious and parasitic diseases

- Licensing and registrations

- Prescription drugs

Alternate Title(s) of Bill S 3629

Opioid Treatment Access Act of 2022

A bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency, and for other purposes.